Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01421654 · ClinicalTrials.gov registry record · NA
Evaluation of Acclimate Feature for Positive Airway Pressure (PAP) Therapy
A NA study, sponsored by ResMed.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01421654: Completed NA study, sponsored by ResMed.
NCT01421654 is a NA study that has completed, run by ResMed. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01421654, a NA study, has completed, sponsored by ResMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate if using the Acclimate feature at the beginning of Positive Airway Pressure (PAP) therapy results in patients using their PAP therapy at least as long as they would standard therapy. Additionally, the Acclimate feature will be evaluated with regard to patient comfort, ease of acceptance of PAP therapy, leak events, and respiratory events.
Primary Outcome
The number of hours that each group used the device will be compared between subjects using fixed pressure with the Acclimate mode and subjects using fixed pressure without the Acclimate mode.
Interventions
- DEVICE S9 Elite with Acclimate
- DEVICE S9 Elite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT01421654 record still lists
NCT01421654 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which S9 Elite with Acclimate is the first listed.
NCT01421654 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01421654 about?
NCT01421654 is a clinical study titled "Evaluation of Acclimate Feature for Positive Airway Pressure (PAP) Therapy". The purpose of the study is to evaluate if using the Acclimate feature at the beginning of Positive Airway Pressure (PAP) therapy results in patients using their PAP therapy at least as long as they would standard therapy. Additionally, the Acclimate feature will be evaluated with regard to patient ...
What is the current status of trial NCT01421654?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01421654?
The interventions under investigation include: S9 Elite with Acclimate (DEVICE), S9 Elite (DEVICE).
Who is sponsoring clinical trial NCT01421654?
This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01421654's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia